🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationCompounded tirzepatide formulation challenges — looking for input Page 8

Compounded tirzepatide formulation challenges — looking for input

Dr.EndoIndy Tue, Jul 9, 2024 at 8:50 AM 43 replies 2,583 viewsPage 8 of 9
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Jul 18, 2024 at 6:01 PM#36
paige_pharma said:
It helps to ask what evidence would change your mind before you look at any.

Adding the part of the answer the thread has not reached. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Worth separating that from compounded supply, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Jul 18, 2024 at 8:01 PM
12 12PurityPaulOR, MaxMetOK, MounjBrad and 9 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Jul 19, 2024 at 6:04 AM#37

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Jul 19, 2024 at 9:04 AM
11 11VanRx_Mike, steve_okc, dave_SLC and 8 others
Reply Quote Save Share Report
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Jul 19, 2024 at 6:08 PM#38

Following on from paige_pharma — and this may be the naive question:

What would you measure differently if you were starting again?

10 10LibrarianMeg, bri_stats, pete_manc_UK and 7 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Jul 20, 2024 at 6:12 AM#39
kate.chem said:
If you are going to change something, change one thing and give it long enough to express itself.

I read this differently from kate.chem, on substance rather than tone. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

9 9wanda_boise, NurseAsh_DET, BenResearch_OR and 6 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Jul 20, 2024 at 6:16 PM#40
kate.chem said:
If you are going to change something, change one thing and give it long enough to express itself.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

37 12hyun_seoul, jim_asheville, matt_MKE and 34 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register